Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
T-Inplant was a German medical device company that specialized in the development and manufacturing of innovative titanium implants for spinal surgery. The company's primary product was the T-Inplant, a cervical interbody fusion system designed to provide stable fixation and promote osseointegration in patients with degenerative disc disease. Its unique design focused on maintaining spinal alignment while facilitating natural bone growth across the disc space. In 2014, the company and its intellectual property were acquired by SIGNUS Medizintechnik, which integrated the technology into its broader portfolio of orthopedic and spinal solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tinplant.